05:40 PM EST, 02/04/2025 (MT Newswires) -- Qiagen ( QGEN ) said Tuesday the German Federal Patent Court reaffirmed the validity of a patent protecting its QuantiFeron technology.

The court's decision upholds Qiagen's ( QGEN ) intellectual property rights involving the German part of a European patent, which protects its technology in detecting latent tuberculosis, the company said late Tuesday.

"Patents covering these innovations have been issued to Qiagen ( QGEN ) in several other countries, and form part of a group of more than 120 patents currently issued for QuantiFERON," the company added.